2006
DOI: 10.1177/0892705706056463
|View full text |Cite
|
Sign up to set email alerts
|

Poly(vinyl chloride) and Poly(e-caprolactone) Blends for Medical Use

Abstract: This study examines the possibility of replacing partially or totally the di(2-ethylhexyl) phthalate (DEHP -low molecular plasticizer) from the poly(vinyl chloride) (PVC) compositions intended for medical devices, with poly("-caprolactone) (PCL -biodegradable, biocompatible, and macromolecular plasticizer). Nine different plasticized PVC (PVC-P) compositions are analyzed from the viewpoint of thermal and mechanical properties, plasticizer loss, and extraction behavior in different medical media. After comparin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
26
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(40 citation statements)
references
References 24 publications
6
26
0
1
Order By: Relevance
“…DSC analysis was performed on unloaded and loaded PCL fibrous matrices (Supplementary Figure 4) and the corresponding thermodynamic parameters (melting temperature of the polymer, T f and correspondent enthalpy change, Δ H ) are presented in Table 1. Unloaded PCL fibers presented the characteristic melting peak of the polymer, at around 57°C in agreement with other reports (Rusu et al, 2006). This temperature is maintained after inclusion of the bioactives in the polymeric matrix.…”
Section: Resultssupporting
confidence: 92%
“…DSC analysis was performed on unloaded and loaded PCL fibrous matrices (Supplementary Figure 4) and the corresponding thermodynamic parameters (melting temperature of the polymer, T f and correspondent enthalpy change, Δ H ) are presented in Table 1. Unloaded PCL fibers presented the characteristic melting peak of the polymer, at around 57°C in agreement with other reports (Rusu et al, 2006). This temperature is maintained after inclusion of the bioactives in the polymeric matrix.…”
Section: Resultssupporting
confidence: 92%
“…In general, plasticisers can leach from the polymer matrix, as they are not covalently bonded to the polymer. There is also a risk of drugs in the body migrating into plastics, which could lead to drugs falling below the therapeutic threshold [77].…”
Section: Poly(vinyl Chloride)mentioning
confidence: 99%
“…The incorporation of PCL was found to significantly reduce the melt viscosity of the matrix, thus indicating that PCL provides a plasticizing effect which is to be expected owing to the low melt viscosity of the Virgin PCL in comparison to Virgin PEO. The plasticizing effect of PCL has been well documented in literature and PCL has been used as a replacement for di(2-ethylhexyl) phthalate (DEHP) in poly(vinyl) chloride (PVC) compositions intended for medical device applications [41]. Blend 3 and Blend 4 displayed a lower melt viscosity than that of Virgin PCL and this reduction in melt viscosity can be attributed to the inclusion of the lower molecular weight PCL (M w 37,000).…”
Section: Melt Flow Indexmentioning
confidence: 99%